A Silver Lining in the VAD Sky

A Silver Lining in the VAD Sky: Impact of Silver Dressing on LVAD Associated Driveline Infection

NCT05163392•University of California, San Francisco

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

LVAD (Left Ventricular Assist Device) Driveline Infection

Interventions

Silverlon

Control

Locations

United States

Locations (1)

UCSF Parnassus

San Francisco, California, United States

Key Dates

Start Date

February 1, 2022

Primary Completion Date

December 1, 2024

Completion Date

January 26, 2026

Last Updated

February 13, 2026

Sponsors

Lead Sponsor

University of California, San Francisco

Collaborators

International Consortium of Circulatory Assist Clinicians

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 13, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions